Neuronetics, Inc. — Form SCHEDULE 13D/A
Filed August 24, 2026 · analyzed by the Ownership Agent
SCHEDULE 13D/A
— Neutral
significance 12/100
What the filing says
On August 14, 2026, the reporting person purchased 14,000 shares of Neuronetics common stock at a weighted average price of $3.16 per share (range $3.13–$3.17), for a total acquisition cost of approximately $44,240. This represents an incremental position increase by an existing substantial shareholder.
Why this rating
Routine insider accumulation; $44K purchase is 0.03% of company's $129M market cap. No control threshold crossed; standard disclosure.
See more from August 24, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.